v3.25.1
Consolidated Balance Sheets
$ in Thousands, € in Millions
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Current assets    
Cash and cash equivalents $ 54,486 $ 45,167
Investment securities, available-for-sale 20,216 28,611
Restricted cash, current 261 3,263
Accounts receivable, net of allowances 926 949
Inventory 2,294 3,874
Other current assets 4,287 4,890
Total current assets 82,470 86,754
Property and equipment, net 7,061 9,032
Operating lease right-of-use assets 16,746 13,758
Restricted cash, net of current portion 1,500 961
Intangible assets, net 10,972 17,235
Other assets 2,412 1,895
Total assets 121,161 129,635
Current liabilities    
Accounts payable 1,132 2,271
Accrued liabilities 2,542 8,640
Accrued liability for Ibeo business combination 6,300
Contract liabilities 308 300
Derivative liability 14,581
Notes payable, current 24,248
Operating lease liabilities, current 2,682 2,323
Other current liabilities 458 669
Total current liabilities 45,951 20,503
Notes payable, net of current portion 8,754
Operating lease liabilities, net of current portion 15,954 12,714
Other long-term liabilities 1,733 614
Total liabilities 72,392 33,831
Commitments and contingencies (Note 11)
Shareholders’ equity    
Preferred stock, par value $0.001; 25,000 shares authorized; zero and zero shares issued and outstanding as of December 31, 2024 and 2023
Common stock, par value $0.001; 310,000 shares authorized; 224,993 and 194,736 shares issued and outstanding as of December 31, 2024 and 2023, respectively 225 195
Additional paid-in capital 910,825 860,765
Accumulated other comprehensive income 210
Accumulated deficit (862,281) (765,366)
Total shareholders’ equity 48,769 95,804
Total liabilities and shareholders’ equity $ 121,161 $ 129,635

Source

HTML PDF
ZIP